Doximity Inc (DOCS)

Doximity CEO Jeffrey Tangney sold 8,505 shares of Class A Common Stock worth approximately $211,000. This sale was a non-discretionary event to cover tax obligations from vested restricted stock units, representing only a 0.3% reduction in his direct holdings. Tangney still retains a significant 1% ownership interest in the company, amounting to over 2.5 million shares.

Doximity's CFO, Matthew Sonefeldt, recently filed a Form 4 showing a non-discretionary disposition of 15,311 shares worth approximately $380,000, solely to cover tax withholding obligations from vested restricted stock units. This transaction is not indicative of his outlook on the company, as he retains significant equity. The article also highlights Doximity's business fundamentals, recent financial performance, and Sonefeldt's focus on long-term growth strategies, drawing parallels to LinkedIn's ad business development.

A Doximity director, Timothy S. Cabral, sold 7,500 shares of Class A Common Stock worth $293,325 on August 7th, the day Doximity's stock surged 33%. The sale was part of a pre-determined Rule 10b5-1 trading plan established in February, indicating it was not timed to the stock's recent jump. While Cabral's direct common stock holdings are now minimal, he retains significant long-term interest through 326,000 derivative securities.

Doximity's Chief Accounting Officer, Siddharth Sitaram, sold 1,770 shares of Class A Common Stock for $44,143 at $24.94 per share. This transaction was part of a Rule 10b5-1 plan to cover tax withholding obligations related to a stock option exercise, where he acquired 5,000 shares. Additionally, 3,882 shares were withheld by Doximity to satisfy tax obligations for restricted stock units.

Doximity's Chief Accounting Officer, Siddharth Sitaram, sold 1,770 shares of Class A Common Stock worth $44,143 on August 13, 2026, as part of a pre-arranged plan to cover tax obligations. Concurrently, he exercised stock options and had shares withheld for additional tax purposes. These transactions occurred while Doximity shares are down 45% year-to-date, though some analysts suggest the stock is undervalued.